Effects of inosine monophosphate dehydrogenase inhibition on high glucose-induced cellular reactive oxygen species in mesangial cells

被引:14
作者
Song, J. S. [1 ]
Huh, K. H. [1 ,2 ]
Park, J. [1 ]
Ju, M. K. [2 ]
Kim, M. S. [1 ,2 ]
Kim, Y. S. [1 ,2 ,3 ]
机构
[1] Yonsei Univ, Coll Med, Res Inst Transplantat, Seoul 120749, South Korea
[2] Yonsei Univ, Coll Med, Dept Surg, Seoul 120749, South Korea
[3] Yonsei Univ, Team Nanobiomat Cell Based Implants BK21, Seoul 120749, South Korea
关键词
D O I
10.1016/j.transproceed.2008.01.016
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 [免疫学];
摘要
Mesangial cell extracellular matrix (ECM) synthesis plays an important role in chronic renal diseases including chronic renal allograft dysfunction and diabetic nephropathy. Although inosine monophosphate dehydrogenase 2 (IMPDH2), as a target of mycophenolic acid (MPA), is important for de novo guanosine synthesis in lymphocytes, mesenchymal cells are not wholly dependent on it. To explore the importance of IMPDH2 on the inhibitory effects of MPA in mesangial cells (MC), we compared the effects of MPA and IMPDH2 siRNA on high glucose (HG)-induced fibronectin secretion and cellular reactive oxygen species (ROS). Mouse mesangial cells (MMC) were stimulated with HG (30 mmol/L D-glucose) in the presence or absence of MPA pretreatment or IMPDH2 siRNA transfection. Fibronectin secretion was measured by Western blot analysis, and dichlorofluorescein (DCF)-sensitive cellular ROS assessed by flow cytometry. HG increased fibronectin secretion by 1.8-fold at 24 hours and DCF-sensitive cellular ROS by 1.5-fold at I hour. MPA at 10 mu mol/L totally inhibited HG-induced fibronectin secretion and cellular ROS in MMC. However, IMPDH2 siRNA only partially suppressed HG-induced fibronectin secretion and cellular ROS. These results suggested that MPA may inhibit HG-induced fibronectin secretion partially through inhibiting cellular ROS and the inhibition of IMPDH2 may be partially involved in the mechanism of MPA.
引用
收藏
页码:464 / 466
页数:3
相关论文
共 8 条
[1]
Mechanisms of action of mycophenolate mofetil in preventing acute and chronic allograft rejection [J].
Allison, AC ;
Eugui, EM .
TRANSPLANTATION, 2005, 80 (02) :S181-S190
[2]
Mycophenolic acid antagonizes the activation of cultured human mesangial cells [J].
Dubus, I ;
Vendrely, B ;
Christophe, I ;
Labouyrie, JP ;
Delmas, Y ;
Bonnet, J ;
Combe, C .
KIDNEY INTERNATIONAL, 2002, 62 (03) :857-867
[3]
Oxidative stress and chronic allograft nephropathy [J].
Ha, H ;
Park, J ;
Kim, YS ;
Endou, H .
YONSEI MEDICAL JOURNAL, 2004, 45 (06) :1049-1052
[4]
Reactive oxygen species and matrix remodeling in diabetic kidney [J].
Ha, H ;
Lee, HB .
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2003, 14 :S246-S249
[5]
Mycophenolic acid inhibits mesangial cell activation through p38 MAPK inhibition [J].
Ha, Hunjoo ;
Kim, Myoung Soo ;
Park, Jehyun ;
Huh, Joo Young ;
Huh, Kyu Ha ;
Ahn, Hyung Joon ;
Kim, Yu Seun .
LIFE SCIENCES, 2006, 79 (16) :1561-1567
[6]
Nankivell Brian J., 2003, New England Journal of Medicine, V349, P2326, DOI 10.1056/NEJMoa020009
[7]
Mycophenolic acid inhibits platelet-derived growth factor-induced reactive oxygen species and mitogen-activated protein kinase activation in rat vascular smooth muscle cells [J].
Park, J ;
Ha, HJ ;
Seo, J ;
Kim, MS ;
Kim, HJ ;
Huh, KH ;
Park, K ;
Kim, YS .
AMERICAN JOURNAL OF TRANSPLANTATION, 2004, 4 (12) :1982-1990
[8]
Tacrolimus and posttransplant diabetes mellitus in renal transplantation [J].
van Hooff, JP ;
Christiaans, MHL ;
van Duijnhoven, EM .
TRANSPLANTATION, 2005, 79 (11) :1465-1469